A Facile Crystallization Strategy To Turn Calcium Bisphosphonates Into Novel Osteogenesis‐Inducing Biomaterials

Chen Zhuang,Guanglin Zhu,Yingjun Wang,Lin Wang,Xuetao Shi,Chuanbin Mao

DOI: https://doi.org/10.1002/adhm.202203004

IF: 10

2023-05-20

Advanced Healthcare Materials

Abstract:Insoluble metal bisphosphonates (BP) are considered an ideal alternative to the soluble counterparts in regenerative medicine due to their increased BP release profile, but still present undesired properties (e.g., low stability, uncontrolled degradation and poor biocompatibility). Through a simple crystallization on a solid calcium hydroxyapatite (HA)‐based substrate from a BP precursor solution in 30 days, we developed a series of insoluble calcium BP (CaBP) crystals. These crystals, including calcium alendronate (CaAln), calcium pamidronate (CaPam), calcium incadronate (CaInc), calcium risedronate (CaRis), calcium zoledronate (CaZol), and calcium di‐minodronate (Ca(Min)2), presented high purity, regular morphologies and excellent biodegradability. We demonstrated that these CaBPs could induce osteogenic differentiation of adipose‐derived mesenchymal stem cells in vitro in the absence of other osteogenic inducers. We further found that CaBP induced bone formation more effectively in a femur defect rabbit model in three months but with a lower in vivo haematotoxicity than the clinically used HA during osteogenesis. We believe that these desired biological properties arise from the capability of our insoluble CaBPs in releasing BPs in a sustained manner for stimulating osteogenesis. This work provides a significant strategy for turning CaBPs into novel biomaterials for tissue regeneration and demonstrates their great potential in the clinic. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials